{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:26:58Z","timestamp":1772166418974,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["SP\/12\/2\/29422"],"award-info":[{"award-number":["SP\/12\/2\/29422"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["FS\/13\/72\/30531"],"award-info":[{"award-number":["FS\/13\/72\/30531"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3270-2","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T09:02:41Z","timestamp":1553504561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2108-9222","authenticated-orcid":false,"given":"Rustam","family":"Al-Shahi Salman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon D.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A. G.","family":"Sandercock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Sprigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathie L. M.","family":"Sudlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Werring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William N.","family":"Whiteley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"issue":"6","key":"3270_CR1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","volume":"85","author":"MT Poon","year":"2014","unstructured":"Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85(6):660\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"3270_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(18)30253-9","volume":"17","author":"R Al-Shahi Salman","year":"2018","unstructured":"Al-Shahi Salman R, Frantzias J, Lee RJ, Lyden PD, Battey TWK, Ayres AM, Goldstein JN, Mayer SA, Steiner T, Wang X, et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol. 2018;17(10):885\u201394.","journal-title":"Lancet Neurol"},{"issue":"7","key":"3270_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/ijs.12309","volume":"9","author":"T Steiner","year":"2014","unstructured":"Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, Forsting M, Harnof S, Klijn CJ, Krieger D, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840\u201355.","journal-title":"Int J Stroke"},{"issue":"7","key":"3270_CR4","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","volume":"46","author":"JC Hemphill 3rd","year":"2015","unstructured":"Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015;46(7):2032\u201360.","journal-title":"Stroke"},{"issue":"2","key":"3270_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJ Asch van","year":"2010","unstructured":"van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167\u201376.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3270_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1474-4422(11)70264-2","volume":"11","author":"JS Balami","year":"2012","unstructured":"Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol. 2012;11(1):101\u201318.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3270_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/01.STR.0000106480.76217.6F","volume":"35","author":"N Chapman","year":"2004","unstructured":"Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, Davis S, Donnan G, MacMahon S, Neal B, et al. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke. 2004;35(1):116\u201321.","journal-title":"Stroke"},{"issue":"9287","key":"3270_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","unstructured":"PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033\u201341.","journal-title":"Lancet"},{"key":"3270_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jns.2017.11.009","volume":"384","author":"X Ding","year":"2018","unstructured":"Ding X, Liu X, Tan C, Yin M, Wang T, Liu Y, Mo L, Wei X, Tan X, Deng F, et al. Resumption of antiplatelet therapy in patients with primary intracranial hemorrhage-benefits and risks: a meta-analysis of cohort studies. J Neurol Sci. 2018;384:133\u20138.","journal-title":"J Neurol Sci"},{"issue":"11","key":"3270_CR10","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/STROKEAHA.110.589143","volume":"41","author":"RW Flynn","year":"2010","unstructured":"Flynn RW, MacDonald TM, Murray GD, MacWalter RS, Doney AS. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke. 2010;41(11):2606\u201311.","journal-title":"Stroke"},{"issue":"8","key":"3270_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/WNL.0b013e3181eee40f","volume":"75","author":"A Biffi","year":"2010","unstructured":"Biffi A, Halpin A, Towfighi A, Gilson A, Busl K, Rost N, Smith EE, Greenberg MS, Rosand J, Viswanathan A. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75(8):693\u20138.","journal-title":"Neurology"},{"issue":"2","key":"3270_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1160\/TH11-06-0439","volume":"107","author":"BH Chong","year":"2012","unstructured":"Chong BH, Chan KH, Pong V, Lau KK, Chan YH, Zuo ML, Lui WM, Leung GK, Lau CP, Tse HF, et al. Use of aspirin in Chinese after recovery from primary intracranial haemorrhage. Thromb Haemost. 2012;107(2):241\u20137.","journal-title":"Thromb Haemost"},{"key":"3270_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.wneu.2017.06.015","volume":"106","author":"KC Teo","year":"2017","unstructured":"Teo KC, Lau GK, Mak RH, Leung HY, Chang RS, Tse MY, Lee R, Leung GK, Siu DC, Cheung RT, et al. Antiplatelet resumption after antiplatelet-related intracerebral hemorrhage: a retrospective hospital-based study. World Neurosurg. 2017;106:85\u201391.","journal-title":"World Neurosurg"},{"issue":"12","key":"3270_CR14","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1160\/TH17-05-0342","volume":"117","author":"A Gonzalez-Perez","year":"2017","unstructured":"Gonzalez-Perez A, Gaist D, de Abajo FJ, Saez ME, Garcia Rodriguez LA. Low-dose aspirin after an episode of haemorrhagic stroke is associated with improved survival. Thromb Haemost. 2017;117(12):2396\u2013405.","journal-title":"Thromb Haemost"},{"issue":"7589","key":"3270_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/bmj.39070.527986.68","volume":"334","author":"P Glasziou","year":"2007","unstructured":"Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ. 2007;334(7589):349\u201351.","journal-title":"BMJ"},{"key":"3270_CR16","first-page":"CD012144","volume":"5","author":"LA Perry","year":"2017","unstructured":"Perry LA, Berge E, Bowditch J, Forfang E, Ronning OM, Hankey GJ, Villanueva E, Al-Shahi Salman R. Antithrombotic treatment after stroke due to intracerebral haemorrhage. Cochrane Database Syst Rev. 2017;5:CD012144.","journal-title":"Cochrane Database Syst Rev"},{"key":"3270_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13063-018-2542-6","volume":"19","author":"R Al-Shahi Salman","year":"2018","unstructured":"Al-Shahi Salman R, Dennis MS, Murray GD, Innes K, Drever J, Dinsmore L, Williams C, White PM, Whiteley WN, Sandercock PAG, et al. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial. Trials. 2018;19:162.","journal-title":"Trials"},{"issue":"4","key":"3270_CR18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/hs0402.105909","volume":"33","author":"C Counsell","year":"2002","unstructured":"Counsell C, Dennis M, McDowall M, Warlow C. Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke. 2002;33(4):1041\u20137.","journal-title":"Stroke"},{"issue":"6","key":"3270_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/bjc.1976.220","volume":"34","author":"R Peto","year":"1976","unstructured":"Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976;34(6):585\u2013612.","journal-title":"Br J Cancer"},{"issue":"526","key":"3270_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","volume":"44","author":"JL Haybittle","year":"1971","unstructured":"Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol. 1971;44(526):793\u20137.","journal-title":"Br J Radiol"},{"issue":"1","key":"3270_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977;35(1):1\u201339.","journal-title":"Br J Cancer"},{"key":"3270_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13063-017-1909-4","volume":"18","author":"AE Maxwell","year":"2017","unstructured":"Maxwell AE, MacLeod MJ, Joyson A, Johnson S, Ramadan H, Bellfield R, Byrne A, McGhee C, Rudd A, Price F, et al. Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study. Trials. 2017;18:162.","journal-title":"Trials"},{"issue":"9314","key":"3270_CR23","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(02)08272-7","volume":"359","author":"TG Clark","year":"2002","unstructured":"Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet. 2002;359(9314):1309\u201310.","journal-title":"Lancet"},{"issue":"3","key":"3270_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(18)30006-1","volume":"17","author":"MA Rodrigues","year":"2018","unstructured":"Rodrigues MA, Samarasekera N, Lerpiniere C, Humphreys C, McCarron MO, White PM, Nicoll JAR, Sudlow CLM, Cordonnier C, Wardlaw JM, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018;17(3):232\u201340.","journal-title":"Lancet Neurol"},{"issue":"9","key":"3270_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","volume":"137","author":"KA Hicks","year":"2018","unstructured":"Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, et al. 2017 Cardiovascular and stroke endpoint definitions for clinical trials. Circulation. 2018;137(9):961\u201372.","journal-title":"Circulation"},{"issue":"23","key":"3270_CR26","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736\u201347.","journal-title":"Circulation"},{"issue":"5","key":"3270_CR27","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1161\/STROKEAHA.109.571562","volume":"41","author":"A Bruno","year":"2010","unstructured":"Bruno A, Shah N, Lin C, Close B, Hess DC, Davis K, Baute V, Switzer JA, Waller JL, Nichols FT. Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke. 2010;41(5):1048\u201350.","journal-title":"Stroke"},{"issue":"3","key":"3270_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/STROKEAHA.111.639708","volume":"43","author":"M Dennis","year":"2012","unstructured":"Dennis M, Mead G, Doubal F, Graham C. Determining the modified Rankin score after stroke by postal and telephone questionnaires. Stroke. 2012;43(3):851\u20133.","journal-title":"Stroke"},{"issue":"8","key":"3270_CR29","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.111.613273","volume":"42","author":"A Bruno","year":"2011","unstructured":"Bruno A, Akinwuntan AE, Lin C, Close B, Davis K, Baute V, Aryal T, Brooks D, Hess DC, Switzer JA, et al. Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke. 2011;42(8):2276\u20139.","journal-title":"Stroke"},{"issue":"11","key":"3270_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.115.019014","volume":"133","author":"I Ford","year":"2016","unstructured":"Ford I, Murray H, McCowan C, Packard CJ. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study. Circulation. 2016;133(11):1073\u201380.","journal-title":"Circulation"},{"issue":"19","key":"3270_CR31","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.4274","volume":"30","author":"P Royston","year":"2011","unstructured":"Royston P, Parmar MK. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med. 2011;30(19):2409\u201321.","journal-title":"Stat Med"},{"issue":"23","key":"3270_CR32","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/jama.2017.18556","volume":"318","author":"C Gamble","year":"2017","unstructured":"Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dore C, Williamson PR, Altman DG, Montgomery A, Lim P, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA. 2017;318(23):2337\u201343.","journal-title":"JAMA"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3270-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3270-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3270-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T20:18:53Z","timestamp":1584994733000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3270-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3270"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3270-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.56\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.56\/v2","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Scotland A research ethics committee approved RESTART before recruitment began (reference 12\/SS\/0138).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"183"}}